Hypertension Society’s PATHWAY Studies Group: Spironolactone versus
placebo, bisoprolol, and doxazosin to determine the optimal treatment for
drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover
Authors:Alireza Kamali, Amir Sanatkar, Mehrzad Sharifi, and Esmaeil Moshir
study, and this is probably because of the difference between metoprolol and propranolol with metoral. Another research by Sleilaty et al. [ 26 ] compared the effects of amiodarone and bisoprolol in reducing the occurrence frequency of post-CABG AF
Authors:Kristóf Rácz, Tamás Tiszai-Szűcs, János Gál, and Miklós Kertai D.
Poldermans, D., Boersma, E., Bax, J. J. és mtsai:
The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress